Global Information
회사소개 | 문의

세계의 심혈관계 의약품 시장 : 고혈압 치료제, 지질저하약, 항혈전제, 기타(울혈성심부전약, 항부정맥약, 협심증 치료제)

Cardiovascular Drugs Global Market Report 2019

리서치사 The Business Research Company
발행일 2019년 01월 상품 코드 531324
페이지 정보 영문 300 Pages
가격
US $ 4,000 ₩ 4,555,000 PDF by E-mail (Single User License)
US $ 6,000 ₩ 6,833,000 PDF by E-mail (Site License)
US $ 8,000 ₩ 9,111,000 PDF by E-mail (Enterprise License)


세계의 심혈관계 의약품 시장 : 고혈압 치료제, 지질저하약, 항혈전제, 기타(울혈성심부전약, 항부정맥약, 협심증 치료제) Cardiovascular Drugs Global Market Report 2019
발행일 : 2019년 01월 페이지 정보 : 영문 300 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 심혈관계 의약품 시장을 조사했으며, 시장 정의와 개요, 시장에 대한 각종 영향요인 분석, 질환 부문·지역·국가별 동향과 시장 규모 추이 및 예측, 거시경제 요인·헬스케어 시장 전체·각종 산업 지표와의 비교, 경쟁 환경, 기업 개요 등을 정리하여 전해드립니다.

제1장 시장의 특징

제2장 시장 규모·성장률

  • 시장 성장 : 현재까지의 경위
    • 성장 촉진요인
    • 성장 억제요인
  • 시장 성장 : 예측
    • 성장 촉진요인
    • 성장 억제요인

제3장 PESTLE 분석

제4장 고객 정보

제5장 심혈관계 의약품 시장 분석 : 세분화별

  • 세계 시장의 실적 : 부문별
    • 고혈압 치료제
    • 지질저하약
    • 항혈전제
    • 기타
      • 혈성 심부전
      • 항부정맥약
      • 협심증 치료제
  • 세계 시장의 추이와 예측 : 부문별
  • 시장 동향·전략

제6장 심혈관계 의약품 시장 분석 : 지역·국가별 분석

  • 세계 시장의 실적 : 지역별
  • 세계 시장의 추이와 예측 : 지역별
  • 시장 실적 : 국가별
  • 시장의 추이와 예측 : 국가별
  • 세계 의약품 시장의 실적 : 부문·지역별
  • 세계 의약품 시장의 실적 : 부문·국가별

제7장 거시경제 요인과 시장의 비교

  • 시장 규모의 GDP에서 차지하는 비율
  • 1인당 평균 지출액

제8장 거시경제 요인과 시장의 비교 : 국가별

  • 시장 규모의 GDP에서 차지하는 비율 : 국가별
  • 1인당 평균 지출액 : 국가별

제9장 산업 지표와 시장의 비교

  • 세계의 약제사 수 : 국가별
  • 시장 매출 vs 약제사 수 : 국가별
  • 세계의 의약품회사 수 : 국가별
  • 시장 매출 vs 의약품회사 수 : 국가별
  • 세계의 R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 시장 매출 vs R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 세계의 제네릭 & 브랜드 매출 비율 : 국가별
  • 시장 매출 vs 제네릭 & 브랜드 매출 비율 : 국가별
  • 세계의 일반 개업의 수 : 국가별
  • 시장 매출 vs 일반 개업의 수 : 국가별

제10장 아시아태평양 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 중국
  • 인도
  • 일본
  • 호주

제11장 서유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인

제12장 동유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 러시아

제13장 북미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 미국

제14장 남미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 브라질

제15장 중동 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별

제16장 아프리카 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별

제17장 경쟁 환경

  • 기업 개요
  • Johnson & Johnson
  • Novartis Ag
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Sanofi

제18장 주요 M&A

제19장 시장 배경 : 심혈관계 의약품 시장

제20장 헬스케어 산업의 파이낸셜 마진

제21장 부록

KSA 17.08.07

Cardiovascular Drugs Market Global Report 2019 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the cardiovascular drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cardiovascular Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The cardiovascular drugs market section of the report gives context. It compares the cardiovascular drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cardiovascular drugs indicators comparison.

Scope

Markets Covered: Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)

Companies Mentioned: Merck & Co, Sanofi S.A, Pfizer Inc, Bristol-Myers Squibb Company, Novartis AG

Metrics Covered: Hypertension Prevalence Rate, Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, cardiovascular drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Cardiovascular Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Cardiovascular Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Cardiovascular Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Cardiovascular Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Cardiovascular Drugs Market Trends And Strategies

8. Cardiovascular Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Cardiovascular Drugs Market Regional Analysis

  • 9.1. Global Cardiovascular Drugs Market, 2018, By Region, Value ($ Billion)
  • 9.2. Global Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 9.3. Global Cardiovascular Drugs Market, Growth And Market Share Comparison, By Region

10. Cardiovascular Drugs Market Segmentation

  • 10.1. Global Cardiovascular Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
    • 10.1.1. Anti-Hypertensive Drugs
    • 10.1.2. Hypolipidemics
    • 10.1.3. Anti Thrombotics
    • 10.1.4. Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)

11. Cardiovascular Drugs Market Metrics

  • 11.1. Cardiovascular Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • 11.2. Per Capita Average Cardiovascular Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Cardiovascular Drugs Market

  • 12.1. Asia-Pacific Cardiovascular Drugs Market Overview
  • 12.2. Asia-Pacific, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Cardiovascular Drugs Market Metrics
    • 12.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
    • 12.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, Asia-Pacific Countries
  • 12.6. Asia-Pacific Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7. Asia-Pacific Cardiovascular Drugs Market: Country Analysis
    • 12.7.1. China Cardiovascular Drugs Market
      • 12.7.1.1. China Cardiovascular Drugs Market Overview
      • 12.7.1.2. China Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.1.3. China Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.1.4. China Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.2. Australia Cardiovascular Drugs Market
      • 12.7.2.1. Australia Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.2.2. Australia Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.2.3. Australia Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.3. Hong Kong Cardiovascular Drugs Market
      • 12.7.3.1. Hong Kong Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.4. India Cardiovascular Drugs Market
      • 12.7.4.1. India Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.4.2. India Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.4.3. India Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.5. Indonesia Cardiovascular Drugs Market
      • 12.7.5.1. Indonesia Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.6. Japan Cardiovascular Drugs Market
      • 12.7.6.1. Japan Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.6.2. Japan Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.6.3. Japan Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.7. Malaysia Cardiovascular Drugs Market
      • 12.7.7.1. Malaysia Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.8. New Zealand Cardiovascular Drugs Market
      • 12.7.8.1. New Zealand Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.9. Philippines Cardiovascular Drugs Market
      • 12.7.9.1. Philippines Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.10. Singapore Cardiovascular Drugs Market
      • 12.7.10.1. Singapore Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.11. South Korea Cardiovascular Drugs Market
      • 12.7.11.1. South Korea Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.12. Thailand Cardiovascular Drugs Market
      • 12.7.12.1. Thailand Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.13. Vietnam Cardiovascular Drugs Market
      • 12.7.13.1. Vietnam Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Cardiovascular Drugs Market

  • 13.1. Western Europe Cardiovascular Drugs Market Overview
  • 13.2. Western Europe, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 13.3. Western Europe, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 13.4. Western Europe, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Cardiovascular Drugs Market Metrics
    • 13.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, Western Europe Countries
    • 13.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, Western Europe Countries
  • 13.6. Western Europe Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7. Western Europe Cardiovascular Drugs Market: Country Analysis
    • 13.7.1. Austria Cardiovascular Drugs Market
      • 13.7.1.1. Austria Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.2. Belgium Cardiovascular Drugs Market
      • 13.7.2.1. Belgium Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.3. Denmark Cardiovascular Drugs Market
      • 13.7.3.1. Denmark Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.4. Finland Cardiovascular Drugs Market
      • 13.7.4.1. Finland Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.5. France Cardiovascular Drugs Market
      • 13.7.5.1. France Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.5.2. France Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.5.3. France Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.6. Germany Cardiovascular Drugs Market
      • 13.7.6.1. Germany Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.6.2. Germany Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.6.3. Germany Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.7. Ireland Cardiovascular Drugs Market
      • 13.7.7.1. Ireland Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.8. Italy Cardiovascular Drugs Market
      • 13.7.8.1. Italy Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.8.2. Italy Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.8.3. Italy Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.9. Netherlands Cardiovascular Drugs Market
      • 13.7.9.1. Netherlands Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.10. Norway Cardiovascular Drugs Market
      • 13.7.10.1. Norway Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.11. Portugal Cardiovascular Drugs Market
      • 13.7.11.1. Portugal Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.12. Spain Cardiovascular Drugs Market
      • 13.7.12.1. Spain Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.12.2. Spain Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.12.3. Spain Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.13. Sweden Cardiovascular Drugs Market
      • 13.7.13.1. Sweden Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.14. Switzerland Cardiovascular Drugs Market
      • 13.7.14.1. Switzerland Cardiovascular Drugs Market2013 - 2022, Value ($ Billion)
    • 13.7.15. UK Cardiovascular Drugs Market
      • 13.7.15.1. UK Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.15.2. UK Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.15.3. UK Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Cardiovascular Drugs Market

  • 14.1. Eastern Europe Cardiovascular Drugs Market Overview
  • 14.2. Eastern Europe, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Cardiovascular Drugs Market Metrics
    • 14.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
    • 14.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, Eastern Europe Countries
  • 14.6. Eastern Europe Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14.7. Eastern Europe Cardiovascular Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Cardiovascular Drugs Market,
      • 14.7.1.1. Czech Republic Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.2. Poland Cardiovascular Drugs Market
      • 14.7.2.1. Poland Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.3. Romania Cardiovascular Drugs Market
      • 14.7.3.1. Romania Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.4. Russia Cardiovascular Drugs Market
      • 14.7.4.1. Russia Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 14.7.4.2. Russia Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 14.7.4.3. Russia Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Cardiovascular Drugs Market

  • 15.1. North America Cardiovascular Drugs Market Overview
  • 15.2. North America, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 15.3. North America, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 15.4. North America, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 15.5. North America, Cardiovascular Drugs Market Metrics
    • 15.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, North America Countries
    • 15.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, North America Countries
  • 15.6. North America Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15.7. North America Cardiovascular Drugs Market: Country Analysis
    • 15.7.1. Canada Cardiovascular Drugs Market
      • 15.7.1.1. Canada Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.2. Mexico Cardiovascular Drugs Market
      • 15.7.2.1. Mexico Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.3. USA Cardiovascular Drugs Market
      • 15.7.3.1. USA Cardiovascular Drugs Market Overview
      • 15.7.3.2. USA Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 15.7.3.3. USA Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 15.7.3.4. USA Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Cardiovascular Drugs Market

  • 16.1. South America Cardiovascular Drugs Market Overview
  • 16.2. South America, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 16.3. South America, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 16.4. South America, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 16.5. South America, Cardiovascular Drugs Market Metrics
    • 16.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, South America Countries
    • 16.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, South America Countries
  • 16.6. South America Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7. South America Cardiovascular Drugs Market: Country Analysis
    • 16.7.1. Argentina Cardiovascular Drugs Market
      • 16.7.1.1. Argentina Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.2. Brazil Cardiovascular Drugs Market
      • 16.7.2.1. Brazil Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 16.7.2.2. Brazil Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 16.7.2.3. Brazil Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 16.7.3. Chile Cardiovascular Drugs Market
      • 16.7.3.1. Chile Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.4. Colombia Cardiovascular Drugs Market
      • 16.7.4.1. Colombia Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.5. Peru Cardiovascular Drugs Market
      • 16.7.5.1. Peru Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.6. Venezuela Cardiovascular Drugs Market
      • 16.7.6.1. Venezuela Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Cardiovascular Drugs Market

  • 17.1. Middle East Cardiovascular Drugs Market Overview
  • 17.2. Middle East, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.3. Middle East, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.4. Middle East, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Cardiovascular Drugs Market Metrics
    • 17.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, Middle East Countries
    • 17.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, Middle East Countries
  • 17.6. Middle East Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 17.7. Middle East Cardiovascular Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Cardiovascular Drugs Market
      • 17.7.1.1. Saudi Arabia Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.2. Israel Cardiovascular Drugs Market
      • 17.7.2.1. Israel Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.3. Turkey Cardiovascular Drugs Market
      • 17.7.3.1. Turkey Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.4. UAE Cardiovascular Drugs Market
      • 17.7.4.1. UAE Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Cardiovascular Drugs Market

  • 18.1. Africa Cardiovascular Drugs Market Overview
  • 18.2. Africa, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.3. Africa, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.4. Africa, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Cardiovascular Drugs Market Metrics
    • 18.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, Africa Countries
    • 18.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, Africa Countries
  • 18.6. Africa Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 18.7. Africa Cardiovascular Drugs Market: Country Analysis
    • 18.7.1. Egypt Cardiovascular Drugs Market
      • 18.7.1.1. Egypt Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.2. Nigeria Cardiovascular Drugs Market
      • 18.7.2.1. Nigeria Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.3. South Africa Cardiovascular Drugs Market
      • 18.7.3.1. South Africa Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)

19. Cardiovascular Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Merck & Co
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Company Cardiovascular Drugs Market Structure And Strategy
      • 19.3.1.3. Company Cardiovascular Drugs Market Products And Services
      • 19.3.1.4. Financial Performance
    • 19.3.2. Sanofi S.A
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Company Cardiovascular Drugs Market Structure And Strategy
      • 19.3.2.3. Company Cardiovascular Drugs Market Products And Services
      • 19.3.2.4. Financial Performance
    • 19.3.3. Pfizer Inc
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Company Cardiovascular Drugs Market Structure And Strategy
      • 19.3.3.3. Company Cardiovascular Drugs Market Products And Services
      • 19.3.3.4. Financial Performance
    • 19.3.4. Bristol-Myers Squibb Company
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Company Cardiovascular Drugs Market Structure And Strategy
      • 19.3.4.3. Company Cardiovascular Drugs Market Products And Services
      • 19.3.4.4. Financial Performance
    • 19.3.5. Novartis AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Company Cardiovascular Drugs Market Structure And Strategy
      • 19.3.5.3. Company Cardiovascular Drugs Market Products And Services
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Cardiovascular Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Cardiovascular Drugs Market In 2022- Growth Countries
  • 22.2. Global Cardiovascular Drugs Market In 2022- Growth Segments
  • 22.3. Global Cardiovascular Drugs Market In 2022- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top
전화 문의
F A Q
 
BCC Research